FDA Inspection
Puremedy Inc.Puremedy Inc. – FDA Inspection, Feb 12, 2024
Record Details
This FDA Inspection record concerns Puremedy Inc., with an inspection on February 12, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 439647de-891f-41da-bd91-108dc6785233
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229644
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
- 21 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Puremedy Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Puremedy Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.